According to the ROC analysis in our paper, the diagnostic accuracy of NRAS, FGF1, KDR, and NGF for discriminating metastatic CRC patients from non-metastatic CRC patients had a reasonable AUC, specificity, and sensitivity. This evidence concerns the gene FGF1 and colorectal carcinoma.